Imprimis posts $4.9 million in quarterly revenue

Imprimis Pharmaceuticals reported total revenues of $4.9 million in the third quarter compared with $2.7 million a year ago, according to a company press release. Quarterly ophthalmology-related revenue increased 254% to $3 million.